Literature DB >> 12615282

Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology.

Susan M Fernandes1, Jane W Newburger, Peter Lang, Dorothy D Pearson, Jeffrey A Feinstein, Kimberlee Gauvreau, Michael J Landzberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12615282     DOI： 10.1016/s0002-9149(02)03328-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  18 in total

Review 1.  Pulmonary hypertension complicating congenital heart disease.

Authors:  J Eduardo Rame
Journal:  Curr Cardiol Rep       Date:  2009-07       Impact factor: 2.931

2.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: complex congenital cardiac lesions.

Authors:  Candice K Silversides; Omid Salehian; Erwin Oechslin; Markus Schwerzmann; Isabelle Vonder Muhll; Paul Khairy; Eric Horlick; Mike Landzberg; Folkert Meijboom; Carole Warnes; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

3.  Advanced therapies in patients with congenital heart disease-related pulmonary arterial hypertension: results from a long-term, single center, real-world follow-up.

Authors:  Silvia Favilli; Gaia Spaziani; Piercarlo Ballo; Veronica Fibbi; Gennaro Santoro; Enrico Chiappa; Chiara Arcangeli
Journal:  Intern Emerg Med       Date:  2015-01-09       Impact factor: 3.397

Review 4.  Perioperative Care of Children with Eisenmenger Syndrome Undergoing Non-cardiac Surgery.

Authors:  Bibhuti B Das
Journal:  Pediatr Cardiol       Date:  2015-05-10       Impact factor: 1.655

Review 5.  Surgical treatment for adult congenital heart disease: consideration for indications and procedures.

Authors:  Kozo Matsuo; Masashi Kabasawa; Soichi Asano; Shigeru Tateno; Yasutaka Kawasoe; Yoshitomo Okajima; Naoki Hayashida; Hirokazu Murayama
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-11-08

Review 6.  Endothelin receptor antagonist therapy in congenital heart disease with shunt-associated pulmonary arterial hypertension: a qualitative systematic review.

Authors:  N Fine; B Dias; G Shoemaker; S Mehta
Journal:  Can J Cardiol       Date:  2009-03       Impact factor: 5.223

Review 7.  Insight into Pulmonary Arterial Hypertension Associated with Congenital Heart Disease (PAH-CHD): Classification and Pharmacological Management from a Pediatric Cardiological Point of View.

Authors:  I-Chen Chen; Zen-Kong Dai
Journal:  Acta Cardiol Sin       Date:  2015-11       Impact factor: 2.672

Review 8.  Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.

Authors:  Nazzareno Galie; Alessandra Manes; Massimiliano Palazzini; Luca Negro; Alessandro Marinelli; Simona Gambetti; Elisabetta Mariucci; Andrea Donti; Angelo Branzi; Fernando M Picchio
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 9.  Perioperative pharmacological management of pulmonary hypertensive crisis during congenital heart surgery.

Authors:  Nathan Brunner; Vinicio A de Jesus Perez; Alice Richter; François Haddad; André Denault; Vanessa Rojas; Ke Yuan; Mark Orcholski; Xiaobo Liao
Journal:  Pulm Circ       Date:  2014-03       Impact factor: 3.017

10.  Pulmonary hypertension in adult congenital heart disease.

Authors:  Josanna Rodriguez-Lopez
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.